Brexit means little for biotech stocks, analyst says
Global Small-Cell Lung Cancer Pipeline Review, H1 2016 - Analysis, Technologies & Forecasts - Key Vendors: 4SC, Amgen , Johnson & Johnson - Research and Markets
These Gold-rated funds have Morningstar Sustainability Ratings of High despite not explicitly trying to do so.
Technavio Announces Top Ten Vendors in the Global Chronic Lymphocytic Leukemia Market from 2016 to 2020
CFO Network Members -- WSJ
Medivation Files Definitive Consent Revocation Statement and Mails Letter to Stockholders
Global Atherosclerosis Pipeline Report 2016 - Review of 40 Companies & Drug Profiles - Research and Markets
Competitor Analysis: Biosimilar and Biosuperior Anti-TNF Antibodies - 2016 Update with Compilation of Currently Active R&D Projects - Research and Markets
New Data for KEYTRUDA® (pembrolizumab) in Combination with Talimogene Laherparepvec, Dabrafenib Plus Trametinib, or Low-Dose Ipilimumab in Advanced Melanoma Presented at 2016 ASCO Annual Meeting
The firm’s recent pipeline productivity should help stabilize its wide economic moat, writes Morningstar’s Karen Anderson.